Curaleaf (OTCMKTS:CURLF) Trading Up 6.2% – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price rose 6.2% during trading on Monday . The stock traded as high as $10.20 and last traded at $10.0475. Approximately 105,761 shares changed hands during trading, a decline of 69% from the average daily volume of 340,157 shares. The stock had previously closed at $9.46.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Curaleaf presently has a consensus rating of “Buy”.

Curaleaf Stock Performance

The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56. The firm’s 50 day simple moving average is $7.61 and its 200 day simple moving average is $7.52. The firm has a market capitalization of $2.34 billion, a price-to-earnings ratio of -25.69 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.51. The firm had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. Sell-side analysts forecast that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.